Seminar: Exploring Export Markets for Health Sector Companies – USA, UAE, and Germany | 29 August

📅 Date: 29 August 2025
📍 Location: Tehnopol (Saturn), Teaduspargi 6/1, Tallinn, Estonia
📝 Pre-registration: Now open – help us tailor the day to your interests

Join us for a practical, insight-packed seminar introducing the USA, the United Arab Emirates, and Germany as target markets for health and biotech companies. Gain real-world knowledge from top experts and start building connections that matter.

🔎 Why attend?
You will learn:

✅ How to navigate regulatory requirements
✅ What types of partners to look for
✅ Which strategies have proven effective
✅ How to avoid the most common pitfalls

🧭 Agenda

10:30–11:00	☕ Arrival & Morning Coffee – Networking and participant registration	Tehnopol (Saturn), Teaduspargi 6/1, Tallinn, Estonia
11:00–11:15	Welcome & Introduction – Overview of the dayModerator: Ain Aaviksoo, Head of Development \| Partner at Heba, Senior Business Advisor at Nortal
11:15–12:00	Panel Discussion: What Unites and What Differentiates These Markets?Arutelus osalevad: Elizabeth Jennings, Dr. Khulood Alsayegh, Dr Stephan Binder Moderator: Ain Aaviksoo, Head of Development \| Partner at Heba, Senior Business Advisor at Nortal
12:00–12:45	🇺🇸 Focus on USA – Elizabeth Jennings, Managing Partner, Venture Atlas Labs + Q&A
12:45–13:30	🇦🇪 Focus on United Arab Emirates – Dr. Khulood Alsayegh, Healthcare Policy Regulator, Dubai Health Authority + Q&A
13:30–14:30	🍽️ Lunch & Networking
14:30–15:15	🇩🇪 Focus on Germany – Dr. rer. nat. Stephan BINDER, Co-Founder and COO, Kalms Consulting + Q&A
15:15–16:45	1:1 Market Access Meetings (by pre-registration): Participants will have the opportunity to book individual 1:1 meetings with market experts based on their preferred region: – USA – Elizabeth Jennings – UAE – Dr. Khulood Alsayegh – Germany – Dr. Stephan Binder These personalised sessions will focus on: – Practical steps for market entry – Specific questions from participants – Key do’s & don’ts based on real-world experience Meetings are scheduled based on pre-registration and availability.
16:45–16:50	Wrap-Up & Next Steps
16:50–17:30	☕ Open Networking & Coffee

👤 Speakers

🇺🇸 Elizabeth Jennings

Managing Partner, Venture Atlas Labs (USA)
🔗 LinkedIn Profile

As a Managing Partner at Venture Atlas Labs, a commercialisation firm that supports global companies in US market success alongside investors, government agencies, and innovation centres, Elizabeth is focused on solving the most challenging commercial problems that new healthcare technologies face. In addition to strategic partnership creation through VAL’s SCALE programme and capital syndication with CVCs, her expertise is in aligning commercial models between countries to enable greater scale, stronger health economics, and much quicker adoption.
She is retained by various investment funds, governments, and international agencies; is the international partner for the American College of Cardiology’s MedAxiom; serves as a grant reviewer for the US Department of Defence; and is a frequent speaker at workshops and conferences. She has authored multiple studies and guidebooks commissioned by foreign trade agencies, including “US Health Economics: How the US Thinks About Value from Fee-for-Service to Value-Based Models” for New Zealand, “Value-Based Model Translation and Care in the US”, and “Commercialisation and Procurement for US Hospitals” for Denmark.
She has worked on each side of the innovation ecosystem in the US, as well as Australia, Latin America, Canada, and Europe, and across startups, large public companies, academia, government, and investment. She served one of the fastest-growing impact-driven business angel networks in the US, SWAN Impact, from the Board of Directors for the last five years.

🇦🇪 Dr. Khulood Alsayegh

Healthcare Policy Regulator, Dubai Health Authority (UAE)
🔗 LinkedIn Profile

Dr. Khulood Alsayegh is a physician and healthcare policy expert with over 15 years of experience working in Ireland, the USA, GCC countries, and the United Arab Emirates. She leads the development of clinical standards and guidelines at the Dubai Health Authority and plays a key role in shaping healthcare regulations across the region.
She is the first certified lead assessor for AI ethics in the Middle East and Africa and serves on the UAE’s National Committee for AI Regulation. Her work bridges technology, personalised medicine, and cross-sector innovation. Dr. Alsayegh is also a highly regarded international speaker.

🇩🇪 Stephan Binder,

Co-Founder and COO, Kalms Consulting (Germany)
🔗 LinkedIn Profile

As the Co-Founder and COO of Kalms Consulting, Dr. Stephan Binder is responsible for business development, as well as Kalms Consulting’s networks and strategic partnerships.

He has almost 20 years of strategic and operational consulting experience, such as in the fields of medical devices, diagnostics, healthcare IT and bioscience; as well as in hospital workflows and efficiency. Along with strategic market access and reimbursement, key opinion leader networking and product launches, his experience includes technology transfer and applications for public grants (German and European).

Due to his work in project groups at various Hamburg hospitals (now Asklepios Group), the University of Hamburg, the CFEL (Center for Free-Electron Laser Science) and the constant global expansion of Kalms Consulting’s international network, Stephan has profound international working experience with interdisciplinary teams.

Stephan has a Ph.D. degree in physics, in the fields of optics and bio-organic systems and a certificate in Medical Physics and Technology.

✅ Register Now

Let us know your market(s) of interest so we can tailor the program and arrange possible 1:1 meetings with our speakers.

📩 Registration form link

Seminar: Exploring Export Markets for Health Sector Companies – USA, UAE, and Germany | 29 August | Tallinn